Naoyuki Nakada

Optogenetic vision restoration: translational barriers and emerging therapeutic strategies.

Key translational and drug development challenges, including insufficient light sensitivity, interspecies differences, immune responses to viral vectors and microbial proteins, and the lack of standardized clinical endpoints for patients with profound visual impairment are discussed.